Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 3, 2007, Pages

  Bai, Y ^a   Ye, S ^b   Mortazavi, R ^a   Campese, V ^b   Vaziri, N D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; cGMP; L arginine nitric oxide system; Phosphodiesterase 5; Salt retention; Sympathetic activity

Indexed keywords

ACTIN; CALMODULIN; CAVEOLIN; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE; PHENOL; PHOSPHODIESTERASE V; PLACEBO; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; KIDNEY; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM RETENTION; SYMPATHETIC TONE; WESTERN BLOTTING;

EID: 33847774567     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00157.2006     Document Type: Article

References (36)

1. Barton CH, Ni Z, Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 60: 1083-1087, 2001.
2. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992.
3. Campese VM. Neurogenic factors and hypertension in renal disease. Kidney Int Suppl 75: S2-S6, 2000.
4. Gabbai FB, Blantz RC. Role of nitric oxide in renal hemodynamics. Semin Nephrol 19: 242-250, 1999.
5. Harteneck C, Koesling D, Soling A, Schultz G, Bohme E. Expression of soluble guanylyl cyclase. FEBS Lett 272: 221-223, 1990.
6. Hayakawa H, Raij L. Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31: 266-270, 1998.
7. Kone BC. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health. Semin Nephrol 24: 299-315, 2004.
8. Koo JR, Vaziri ND. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 63: 195-201, 2003.
9. Li Z, Rodriguez-Iturbe B, Ni Z, Shahkarami A, Sepassi L, Vaziri ND. Effect of hereditary obesity on renal expression of NO synthase, caveolin-1, Akt, guanylate cyclase and calmodulin. Kidney Int 68: 2766-2772, 2005.
10. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 216: 139-147, 1998.
11. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol Heart Circ Physiol 266: H1918-H1926, 1994.
12. Mattson DL, Bellehumeur TD. Neural nitric oxide synthase in renal medulla and blood pressure regulation. Hypertension 28: 297-303, 1996.
13. Michel T. Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res 32: 1361-1366, 1999.
14. Mullershausen F, Russwurm M, Thompson WJ, Liu L, Koesling D, Friebe A. Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J Cell Biol 155: 271-278, 2001.
15. Ni Z, Oveisi F, Vaziri ND. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension 34: 552-557, 1999.
16. Ni Z, Vaziri ND. Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens 14: 155-163, 2001.
17. Raij L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 31: 189-193, 1998.
18. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
19. Roberts CK, Barnard RJ, Sindhu RK, Jurezak M, Ehdaei A, Vaziri ND. A high fat refined carbohydrate diet induces endothelial dysfunction, oxidant/antioxidant imbalance and depressed NO synthase expression. J Appl Physiol 98: 203-210, 2005.
20. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58: 1261-1266, 2000.
21. Schmidt H, Pollock JS, Nakane M, Gorsky LD, Forstermann U, Murad F. Purification of a soluble isoform of guanylyl cyclase-activating factor synthase. Proc Natl Acad Sci USA 88: 365-369, 1991.
22. Singh I, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J, Briggs JP. Coordinate regulation of renal expression of nitric oxide synthase, rennin, and angiotensinogen mRNA by dietary salt. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1027-F1037, 1996.
23. Stacey P, Rulten S, Dapling A, Phillips SC. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247: 249-254, 1998.
24. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressure effect of salt. Kidney Int 46: 230-236, 1994.
25. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
26. Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhou XJ. Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol Renal Physiol 274: F642-F649, 1998.
27. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
28. Vaziri ND, Liang K, Ding Y. Increased NO inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56: 1492-1498, 1999.
29. Wagner L, Riggleman A, Erdely A, Couser W, Baylis C. Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 62: 532-536, 2002.
30. Yanaka N, Kotera J, Ohtsuka A, Akatsuka H, Imai Y, Michibata H, Fujishige K, Kawai E, Takebayashi S, Okumura K, Omori K. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem 255: 391-399, 1998.
31. Yang LE, Zhong H, Leog PKK, Perianayagam A, Campese VM, McDonough AA. Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance. Am J Physiol Renal Physiol 284: F1056-F1065, 2003.
32. Ye S, Gamburd M, Mozayeni P, Koss M, Campese VM. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 11: 723-728, 1998.
33. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51: 722-727, 1997.
34. Ying WZ, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-β1. Am J Physiol Renal Physiol 275: F18-F24, 1998.
35. Yuen T, Potter LR, Garbers DL. A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry 29: 10872-10878, 1990.
36. Zhou XJ, Laszick Z, Wang XQ, Silva FG, Vaziri ND. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 300: 762-767, 2002.